¼«ËÙÈü³µ

Weight Drug Suits Highlight Need For Legal Work On Safety

By Gregg Goldfarb ( February 21, 2025, 5:12 PM EST) -- The rapid ascent of glucagon-like peptide-1 receptor agonists, or GLP-1 RAs — such as Novo Nordisk's Ozempic and Wegovy, and Eli Lilly & Co.'s Mounjaro and Zepbound — has revolutionized diabetes management and weight loss....

¼«ËÙÈü³µ is on it, so you are, too.

A ¼«ËÙÈü³µ subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A ¼«ËÙÈü³µ subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience ¼«ËÙÈü³µ today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login